Wire Stories
-
25.9KSumitomo Heavy Industries, Ltd. invests in Alpha Fusion Inc., developer of Astatine based radiopharmaceuticals for Targeted Alpha Therapy
TOKYO–(BUSINESS WIRE)–Sumitomo Heavy Industries, Ltd. (�SHI�) (TOKYO:6302) (Head Office: Shinagawa-ku, Tokyo, President and CEO: Shinji Shimomura) announced the decision to invest in...
-
24.9KSumitomo Heavy Industries, Ltd. invests in Alpha Fusion Inc., developer of Astatine based radiopharmaceuticals for Targeted Alpha Therapy
TOKYO–(BUSINESS WIRE)–Sumitomo Heavy Industries, Ltd. (�SHI�) (TOKYO:6302) (Head Office: Shinagawa-ku, Tokyo, President and CEO: Shinji Shimomura) announced the decision to invest in...
-
24.4KBio-Thera Solutions Announces First Patient Dosed in Phase 1 Study for BAT8008, an Antibody-Drug Conjugate Targeting Trop2 for the Treatment of Advanced Solid Tumors
GUANGZHOU, China–(BUSINESS WIRE)–#ADC–Bio-Thera Solutions, Ltd. (SH: 688177), a commercial-stage pharmaceutical company, today announced that dosing has begun in a Phase 1 clinical...
-
23.6KBio-Thera Solutions Announces First Patient Dosed in Phase 1 Study for BAT8008, an Antibody-Drug Conjugate Targeting Trop2 for the Treatment of Advanced Solid Tumors
GUANGZHOU, China–(BUSINESS WIRE)–#ADC–Bio-Thera Solutions, Ltd. (SH: 688177), a commercial-stage pharmaceutical company, today announced that dosing has begun in a Phase 1 clinical...
-
28.7KBio-Thera Solutions Announces First Patient Dosed in Phase 1 Study for BAT8008, an Antibody-Drug Conjugate Targeting Trop2 for the Treatment of Advanced Solid Tumors
GUANGZHOU, China–(BUSINESS WIRE)–#ADC–Bio-Thera Solutions, Ltd. (SH: 688177), a commercial-stage pharmaceutical company, today announced that dosing has begun in a Phase 1 clinical...
-
26.8KBiocytogen Announces RenLite� Licensing Agreement with Janssen
BEIJING–(BUSINESS WIRE)–#Antibody–Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”) (HKEX: 02315), today announced the signing of a non-exclusive license agreement with Janssen Biotech, Inc.,...
-
24.4K
Biocytogen Announces RenLite� Licensing Agreement with Janssen
BEIJING–(BUSINESS WIRE)–#Antibody–Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”) (HKEX: 02315), today announced the signing of a non-exclusive license agreement with Janssen Biotech, Inc.,...
-
24.8K
Biocytogen Announces RenLite� Licensing Agreement with Janssen
BEIJING–(BUSINESS WIRE)–#Antibody–Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”) (HKEX: 02315), today announced the signing of a non-exclusive license agreement with Janssen Biotech, Inc.,...
-
26.6K2023 World Baseball Classic Begins, Taiwan Excellence Supports
TAIPEI CITY, Taiwan–(BUSINESS WIRE)–The World Baseball Classic (WBC) is returning to Taiwan, after a ten-year hiatus, for the qualifying rounds. The tournament...
-
35.8K2023 World Baseball Classic Begins, Taiwan Excellence Supports
TAIPEI CITY, Taiwan–(BUSINESS WIRE)–The World Baseball Classic (WBC) is returning to Taiwan, after a ten-year hiatus, for the qualifying rounds. The tournament...
To Top